Breast cancer can occur in both women and men. It’s important to keep in mind that most breast lumps are benign (not cancerous). With early detection, breast cancer has an almost 90% survival rate. McGlinn Cancer Institute's approach to comprehensive breast cancer prevention, detection, treatment, and supportive services is complete care.
While breast cancer may be a common cancer among women, it is not common to you. Our compassionate team knows that a breast cancer diagnosis can feel overwhelming. That is why we explain each step of your treatment and make sure you have a plan that is tailored to every stage of your journey.
Terms to Know
- Radiation oncologists - Doctors with special training in using radiation to treat cancer.
- Medical oncologists – Doctors with special training in diagnosing and treating cancer in adults using chemotherapy, hormonal therapy, biological therapy, and targeted therapy.
Types of Breast Cancer
There are many different types of breast cancer. Thy type of breast cancer can be classified by the location in the breast where they began to grow, how much the cancer has grown or spread, and certain features that influence how the cancer behaves. The diagnosis of breast cancer and kind of cancer is identified by biopsy of breast tissue.
Knowing the type of breast cancer you have been diagnosed with helps you and your provider choose the best treatment options for you.
Non-invasive Breast Cancer
When breast cancer is non-invasive (or "in situ"), it has not spread beyond the ducts or lobules into the surrounding breast tissue. Because the blood and lymphatics are in the surrounding tissue, the risk of spread beyond the breast is small.
There are two main types of non-invasive breast cancer:
- Ductal carcinoma in situ (DCIS). Makes up approximately 20% of all breast cancer diagnoses. Patients with DCIS are at risk of recurrence in the breast and a slightly increased risk of developing future breast malignancies. Because of this risk, treatment is often recommended.
- Lobular carcinoma in situ (LCIS). Non-invasive breast cancer that has not spread outside the lobules where it started. Although LCIS is sometimes not considered true breast cancer, patients with LCIS are at risk of developing future breast malignancy and are sometimes offered preventative treatment.
Invasive Breast Cancer
Breast cancer is called invasive (or infiltrating) when it has spread outside the ducts or lobules into the surrounding tissue. Because the blood and lymphatics are in the surrounding tissue, patients with invasive carcinoma are at risk for recurrence in the breast as well as spread beyond the breast. Because of that, most patients with invasive carcinoma are offered both local and systemic therapy.
The two most common types of invasive breast cancer are defined by where in the tumor cells begin to grow. Invasive ductal carcinoma (IDC) is invasive breast cancer that starts in the milk ducts. About 80% of all breast cancers are invasive ductal carcinomas.
Invasive lobular carcinoma (ILC) is invasive breast cancer that starts in the lobules, the glands in the breast that produce milk. It is the second most common type of breast cancer and about 10-20% of invasive breast cancers are invasive lobular carcinomas.
Invasive ductal and lobular carcinoma are similarly treated.
Types of Invasive Carcinoma
Some types of invasive breast cancer have features (determined at biopsy) that affect how they develop and how they are treated:
- Approximately 70-75% of breast tumors are hormone (estrogen and/or progesterone) receptor positive. These tumors are sensitive to hormonal treatment with anti-estrogens.
- Approximately 15% of breast tumors express a protein called HER2/neu. HER2/neu tumors are very sensitive to targeted therapies like trastuzumab (Herceptin).
- Triple-negative breast cancer (TNBC) is an aggressive type of invasive breast cancer that tests negative for estrogen receptors, progesterone receptors and HER2/neu receptors. TNBC is often treated with chemotherapy.
Metastatic breast cancer is invasive breast cancer that has spread (metastasized) beyond the breast to other organs such as the bones, liver, lungs, or brain. Breast cancer can come back in other parts of the body months or years after the original treatment (called a metastatic recurrence).
A small number of patients are initially diagnosed with metastatic disease (called de novo metastatic or Stage IV breast cancer). Breast cancer can recur in the same breast (local recurrence), nearby lymph nodes (regional recurrence), or in another part of the body (metastatic or distant recurrence). Because of this risk, many patients are treated with local treatment to prevent recurrence in the breast and systemic treatments to prevent recurrence in other organs.
Male breast cancer is rare, but it does happen. Fewer than 1% of all breast cancers are diagnosed in men. Most male breast cancers are invasive ductal carcinomas.
Paget disease of the breast is a rare form of breast cancer where cancer cells collect in or around the nipple.
Inflammatory breast carcinoma is a more aggressive form of malignancy seen in approximately 1% of cases.